Journey Medical Capital Expenditures (CapEx) Growth & History (DERM)

Journey Medical's capital expenditures (capex) was $15.0M for fiscal 2024.

View full Journey Medical company overview

Journey Medical annual capital expenditures (capex) history

Journey Medical annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$15.0M$10.0M+200.00%
20232023-12-31$5.0M−$15.0M−75.00%
20222022-12-31$20.0M$10.0M+100.00%
20212021-12-31$10.0M$8.8M+733.33%
20202020-12-31$1.2M

Journey Medical capital expenditures (capex) trends

Between the periods ended 2020-12-31 and 2024-12-31, Journey Medical's capital expenditures (capex) increased from $1.2M to $15.0M, a change of $13.8M. The latest reported quarter, Q4 2023, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Journey Medical source filings ↗

Community posts

It’s quiet here.

No posts about DERM yet. Start the conversation.

Write the first post